In this episode, Alan G. Minsk, AGG Food & Drug team leader, and Anuj Desai, AGG Intellectual Property partner and head of Trademarks, discuss recent developments that remind our audience in the food and drug space that FDA is not the only regu

Business Divorces in the Food and Supplements Space

Sep 27th, 2021 23m 13s

In this episode, Michael E. Burke, partner and co-chair of the Pharmaceutical & Biotechnology industry team is joined by Robert Durkin, an attorney in our Dietary Supplements team, as they discuss issues around business divorces or disputes bet

Fee Waivers for Small Businesses: Who Qualifies for the Small Business User Fee Waiver for Drugs and Biologics and How to Apply from an FDA and Corporate Perspective

Jun 29th, 2021 12m 31s

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and Genevieve M. Razick, an attorney in our Healthcare and Food & Drug practices, along with Leah D. Braukman, an attorney in our Corporate & Finance practice, discuss the specifics

Data Privacy Issues Life Sciences Companies May Encounter

Mar 22nd, 2021 19m 47s

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and co-chair of AGG’s Data Privacy practice, Kevin L. Coy, discuss U.S. and international privacy and data security law issues life sciences companies may encounter such as privacy

FDA Regulation of Rx Drug and Medical Device Advertising and Promotion: 2020 Year in Review

Feb 1st, 2021 20m 31s

In this episode, AGG’s Food & Drug team leader, Alan G. Minsk, and team member, Genevieve M. Razick, give an overview of FDA’s Office of Prescription Drug Promotion’s (OPDP) enforcement of unlawful advertising in 2020.

FDA Regulated Natural Products: Leveraging IP and Regulatory Requirements to Maximize Possible Return on Investment

Jan 1st, 2021 39m 58s

In this episode, partner Kevin M. Bell and of counsel Bob Durkin discuss some of the more interesting issues and challenges they have encountered when working with clients to ensure they maximized opportunities to monetize the greatest value fr

Pandemic Marketing 101: Do’s and Don’ts to Market Your Brands, Products, and Services Safely

Dec 1st, 2020 28m 51s

In this episode, partner Anuj Desai and of counsel Carolina M. Wirth discuss the Federal Trade Commission (FTC) and Food and Drug Administration's (FDA) roles of protecting consumers at the height of a public health crisis and the types of adve

Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products

Nov 1st, 2020 24m 31s

In this episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Brian A. Teras, partner of the Corporate & Securities practice team. They provide an overview of the diligence process, potential red flags, commo

Quality Agreements for FDA-Regulated Products: Looking Under the Hood

Oct 1st, 2020 27m 21s

In our inaugural episode, Alan G. Minsk, partner and leader of the Food & Drug practice team, is joined by Michael E. Burke, co-chair of the Pharmaceuticals & Biologics industry team. They discuss issues around quality agreements for FDA regula

Rate

Contact This Podcast

Get this podcast via API

Join Podchaser to...

Rate podcasts and episodes
Follow podcasts and creators
Create podcast and episode lists
& much more

Unlock more with Podchaser Pro

Audience Insights

Contact Information

Demographics

Charts

Sponsor History

and More!

Resources
Help Center
Blog
API

Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More